Live Feed
NYSE1h 56m left
LSEClosed
FRAClosed
TSX1h 56m left
HKEXClosed
ASXClosed
Vertex Pharmaceuticals' Casgevy Gains FDA Approval for Expanded Sickle Cell Disease Treatment Options
Gilead Sciences Gains FDA Approval for Trodelvy in First-Line Triple-Negative Breast Cancer Treatment
Cardinal Health's Recovery Energizes Healthcare Sector Amidst Positive Market Trends
Humana Foundation Invests Over $12 Million to Combat Emotional Isolation in Seniors and Veterans
Merck Advances HIV Treatment and Faces Regulatory Scrutiny Amidst Market Success
Johnson & Johnson Advances Cancer Care with Tecvayli Endorsement and Planned Acquisition of Firefly Bio
Eli Lilly Enhances Manufacturing via FDA PreCheck, Boosting Biopharma Innovation and Drug Access
Edwards Lifesciences Showcases Trial Successes, Boosting Investor Confidence Amid Market Changes
Cigna's Evernorth Launches AI-Powered Pharmacy Forward to Enhance Specialty Care Access and Efficiency
Becton Dickinson Secures Vizient Contract for Innovative BD CentroVena One Insertion System
AbbVie Advances Dermatological Treatment with Upadacitinib Approval Recommendation for Non-Segmental Vitiligo
CVS Health Expands Obesity Treatment Access for Seniors Amid Medicare Coverage Changes
Zymeworks BC Strategically Acquires Theravance Biopharma to Expand Biotech Portfolio and Innovation
Savara Advances MOLBREEVI as FDA Reviews Biologics License Application for Rare Disease Treatment
SenesTech Strengthens Leadership with Jack Karabees as EVP of Sales for Rodent Management Solutions
Microbot Medical Advances in Minimally Invasive Technologies Amidst Mixed Earnings Performance
Moleculin Biotech's Annamycin Shows Promise in Treating Relapsed/Refractory Acute Myeloid Leukemia
VistaGen Therapeutics Targets Severe Social Anxiety Disorder with New Long-Term Treatment Strategy
DarioHealth Partners with Beluga Health to Innovate Chronic Care Management and Improve Outcomes
Innoviva Advances Biotech Strategy with Nortiva Bio Launch and XACDURO Partnership
Ionis Pharmaceuticals Secures FDA Approval for First Triglyceride-Lowering Drug, Tryngolza
uniQure N.V. Raises $259 Million for Gene Therapy Advancement and Clinical Development
The Joint Corp. Expands Chiropractic Care with New Clinic in Rhode Island
Viking Therapeutics Launches Phase 1 Trial for VK3019, Targeting Obesity Treatment Market
Capricor Therapeutics' Deramiocel Shows Promising Long-Term DMD Treatment Results Amid Market Caution.
Ardelyx Achieves Key Victory With Xphozah's Inclusion in Medicare ESRD Payment System
Sarepta Therapeutics Advances with FDA Applications for Key Gene Therapies Amid Market Challenges
Illumina Expands Board with Daniel Skovronsky to Enhance Innovation and Leadership Diversity
Zimmer Biomet Holdings Boosts Revenue Guidance Amid Robotics and AI Integration Efforts
Theravance Biopharma Acquired by Zymeworks for $17.00 per Share in Cash Deal
Phio Pharmaceuticals Pioneers Innovative RNAi Therapies for Targeted Cancer Treatment
Lantheus Holdings Faces FDA Approval Setback for LNTH-2501 Due to Manufacturing Issues
Ocular Therapeutix Shares Rise on Positive FDA Feedback for Axpaxli AMD Treatment Application
Glaukos Completes Patient Enrollment in Phase 2 Trial of Innovative Eye Treatment GLK-321
Natera Partners with Eledon to Improve Kidney Transplant Outcomes Through Innovative Diagnostics
